The current price of 7733.T is ¥1,845.50 — it has increased by 6.68% since the previous close. Data as of Nov 5, 2026.
7733.T is up 5.46% over the past week, down 5.60% over the past month and down 0.51% over the past year. The price is above its 200-day moving average of ¥1,757.32.
Of the 14 analysts covering Olympus Corporation, 2 rate it a strong buy, 2 rate it a buy, 9 rate it a hold and 1 rates it a strong sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Olympus Corporation has a market capitalization of ¥1.96T. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Olympus Corporation posted earnings of ¥17.76 per share against an estimate of ¥8.40, beating expectations by 111.43%. Upcoming reports are listed in the earnings calendar.
Olympus Corporation reported revenue of ¥240.4B in its most recent quarter, which has increased by 16.41% compared with the same quarter a year earlier. Analysts had expected ¥226.82B.
7733.T trades at a price-to-earnings ratio of 25.9 based on its earnings over the last twelve months.
Yes. Olympus Corporation pays dividends annually. The latest payment of ¥30.00 per share has a payment date of Mar 30, 2027, which corresponds to a dividend yield of 3.25%.
Companies most comparable to Olympus Corporation include Terumo Corporation, Nipro Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., PHC Holdings Corporation and Intuitive Surgical, Inc.
In the latest trading session 7733.T moved between ¥1,790.00 and ¥1,852.00, a range of 3.36% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Olympus Corporation shows a buy rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 7733.T has traded between ¥1,302.50 and ¥2,210.50. The current price is 16.51% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.